These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Suggestion for differential use of graft materials in peripheral bypass operations]. Enzler MA. Zentralbl Chir; 1993 Jan; 118(7):377-82. PubMed ID: 8372517 [Abstract] [Full Text] [Related]
23. [Supragenicular bypass: venous in comparison with synthetic prosthesis (PTFE)]. Achermann A, Gürke L, Stirnemann P. Swiss Surg; 1998 Jan; 4(3):129-32. PubMed ID: 9655007 [Abstract] [Full Text] [Related]
24. Antiplatelet drugs in femoropopliteal vein bypasses: a multicenter trial. McCollum C, Alexander C, Kenchington G, Franks PJ, Greenhalgh R. J Vasc Surg; 1991 Jan; 13(1):150-61; discussion 161-2. PubMed ID: 1987387 [Abstract] [Full Text] [Related]
25. Pathogenesis and prevention of aortocoronary bypass graft occlusion. Chesebro JH, Fuster V. Int J Clin Pharmacol Res; 1986 Jan; 6(4):261-7. PubMed ID: 3531036 [Abstract] [Full Text] [Related]
26. Comparative review of early and intermediate patency rates of polytetrafluoroethylene and autogenous saphenous vein grafts for lower extremity ischemia. Simone ST, Dubner B, Safi AR, DelGuercio P, Shah MA, Zagorin L, Reichle FA. Surgery; 1981 Dec; 90(6):991-9. PubMed ID: 6458915 [Abstract] [Full Text] [Related]
27. Effects of aspirin and dipyridamole on expanded polytetrafluoroethylene graft patency. Green RM, Roedersheimer LR, DeWeese JA. Surgery; 1982 Dec; 92(6):1016-26. PubMed ID: 6755786 [Abstract] [Full Text] [Related]
28. [How long should antithrombotic therapy be continued following aortocoronary bypass surgery?]. Pfisterer M, Jockers G, Regenass S, Schmitt HE, Grädel E, Burkart F. Schweiz Med Wochenschr; 1989 Oct 28; 119(43):1518-20. PubMed ID: 2692145 [Abstract] [Full Text] [Related]
29. Influence of aspirin and dipyridamole on patency of coronary artery bypass grafts. Mayer JE, Lindsay WG, Castaneda W, Nicoloff DM. Ann Thorac Surg; 1981 Mar 28; 31(3):204-10. PubMed ID: 7011226 [Abstract] [Full Text] [Related]
30. Anti-platelet therapy in graft thrombosis: results of a prospective, randomized, double-blind study. Sreedhara R, Himmelfarb J, Lazarus JM, Hakim RM. Kidney Int; 1994 May 28; 45(5):1477-83. PubMed ID: 8072261 [Abstract] [Full Text] [Related]
31. [Dipyridamole and low-dose aspirin in patients with aortocoronary bypass--comparison with anticoagulation]. Pfisterer M, Jockers G, Burkart F, Schmitt HE, Wolff G, Skarvan K, Stulz P, Hasse J, Grädel E. Schweiz Med Wochenschr; 1987 Oct 24; 117(43):1688-92. PubMed ID: 3501162 [Abstract] [Full Text] [Related]
35. The effect of dipyridamole and warfarin on the patency rate of coronary artery bypass grafts. Harjola PT, Frick MH, Meurala H, Valle M. Thorac Cardiovasc Surg; 1983 Dec 24; 31(6):374-6. PubMed ID: 6198760 [Abstract] [Full Text] [Related]
36. Saphenous vein graft patency 1 year after coronary artery bypass surgery and effects of antiplatelet therapy. Results of a Veterans Administration Cooperative Study. Goldman S, Copeland J, Moritz T, Henderson W, Zadina K, Ovitt T, Doherty J, Read R, Chesler E, Sako Y. Circulation; 1989 Nov 24; 80(5):1190-7. PubMed ID: 2680158 [Abstract] [Full Text] [Related]
39. Random control trial of a short course of aspirin and dipyridamole (Persantin) for femorodistal grafts. Clyne CA, Archer TJ, Atuhaire LK, Chant AD, Webster JH. Br J Surg; 1987 Apr 24; 74(4):246-8. PubMed ID: 3555690 [Abstract] [Full Text] [Related]
40. Treatment of claudication with dipyridamole and aspirin. Libretti A, Catalano M. Int J Clin Pharmacol Res; 1986 Apr 24; 6(1):59-60. PubMed ID: 3514494 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]